FDA Must Change Labeling On Heartburn Meds: Watchdog
The U.S. Food and Drug Administration must require so-called black box warning labels alerting consumers to adverse health risks on all proton pump inhibitor drugs used to treat heartburn and other...To view the full article, register now.
Already a subscriber? Click here to view full article